The US embolic protection devices market is anticipated to grow at a significant CAGR of 8.3% during the forecast period. The US is the major revenue contributor to the global embolic protection devices market. The country holds the highest market value due to better healthcare accessibility, healthcare coverage and spending. For instance, heart disease costs about $200 billion each year in the US, as per the American Heart Association. Furthermore, factors such as an increase in the prevalence of CVDs, especially PAD and CAD, valvular heart disease such as arterial stenosis, high awareness regarding the benefits of modern embolic protection devices, vendors aggressive expansion plans to penetrate the US market, and product approvals of new embolic protection devices are likely to fuel the growth of the embolic protection devices market in the country.

Additionally, favorable government reimbursement support is another key factor for the higher adoption of advanced embolic protection devices in the country. For instance, the US Centers for Medicare & Medicaid Services approved for a New Technology Add-on Payment (NTAP) designation for Boston Scientific’s SENTINEL Cerebral Protection System, effective from October 2018. Such additional payment to cover the costs of using embolic protection is likely to influence the embolic protection devices market in the US.

The US embolic protection devices market is segmented based on product, application, and end-user. Based on product, the market is segmented into filter devices and occlusion devices. Based on application, the market is categorized into cardiovascular & peripheral and neurovascular. Based on end-user, the market is fragmented into ambulatory surgery centers, freestanding CATH labs, hospitals, and specialty cardiac centers. 

In addition, owing to the growth opportunity, the country is witnessing significant new product approvals from the key as well as other market players. For instance, key player Boston Scientific received the FDA approval for its SENTINEL Cerebral Protection System in June 2017. Other prominent player, Contego Medical, received the FDA 510(k) approval for the Vanguard IEP device in December 2018. Another, Cardiovascular Systems received FDA approval for WIRION Embolic Protection System in March 2018. Hence, such product approvals are further fueling the embolic protection devices market in the country.

Research Methodology

The market study of the US embolic protection devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. US Embolic Protection Devices Market Research and Analysis by Product
2. US Embolic Protection Devices Market Research and Analysis by Application
3. US Embolic Protection Devices Market Research and Analysis by End-user

The Report Covers

• Comprehensive research methodology of the US embolic protection devices market.
• This report also includes a detailed and extensive market overview with the key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US embolic protection devices market.
• Insights about market determinants which are stimulating the US embolic protection devices market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.